Guillain-Barre Syndrome

Eculizumab May Improve Independent Walking Ability in Guillain-Barré Syndrome

Eculizumab May Improve Independent Walking Ability in Guillain-Barré Syndrome

By

High-dose intravenous immunoglobulin therapy was administered to all patients and may have contributed to neutralization of eculizumab.

Risk for Guillain-Barré Syndrome Associated With Early Life Immune-Mediated Disorders

Risk for Guillain-Barré Syndrome Associated With Early Life Immune-Mediated Disorders

By

Rheumatological disorders were associated with a 7-fold risk of developing Guillain-Barré syndrome.

Development of Guillain-Barré Syndrome Associated With Zika Virus Infection

Development of Guillain-Barré Syndrome Associated With Zika Virus Infection

By

Infection with the Zika virus may increase the risk for development of Guillain-Barré syndrome.

Surgery May Boost Risk of Guillain-Barré in Immuno-Compromised

Surgery May Boost Risk of Guillain-Barré in Immuno-Compromised

Patients with cancer or an autoimmune disease who underwent surgery were at a greater risk.

M. pneumoniae Infection Associated With Guillain-Barré Syndrome

M. pneumoniae Infection Associated With Guillain-Barré Syndrome

Anti-GalC IgG may contribute to the pathogenesis of Guillain-Barré syndrome.

More Evidence Linking Zika and Guillain-Barré Syndrome

More Evidence Linking Zika and Guillain-Barré Syndrome

The CDC recently confirmed the link between Zika virus and microcephaly.

Influenza Vaccination Can Reduce Risk of Guillain-Barré Syndrome

Influenza Vaccination Can Reduce Risk of Guillain-Barré Syndrome

It's unclear whether the effect that the vaccine has on contracting influenza is responsible for the reduced risk.

Sign Up for Free e-newsletters

CME Focus